Every year, insurance plans update the list of drugs that they cover, also known as their formulary. That means that some drugs covered this year won’t be covered next year. (In fact, more and more drugs are excluded from formularies each year.) And drugs that are new to the market might be covered soon. If you rely on health insurance to pay for your medications, now’s a good time to pay attention. See More
Tradjenta (linagliptin) is used to help control blood sugar and treat type 2 diabetes. Tradjenta is slightly more popular than other gliptins. There are currently no generic alternatives to Trajenta.
Check our savings tips for co-pay cards, assistance programs, and other ways to reduce your cost. Tradjenta is covered by most Medicare and insurance plans.
Linagliptin Latest News
Get the latest updates on this drug from the GoodRx medical team
Combination drugs can also be a convenient way to join together two drugs that work differently to treat a particular health condition, and extended release versions like Jentadueto XR mean you only need to take your prescription once per day. In addition, many medications are combined because they work better together than either medication alone. See More
On August 28, 2015, the FDA issued a safety warning for a newer type of type 2 diabetes medication known as DPP-4 inhibitors or gliptins.
There have been reports that these medications can cause severe and possibly disabling joint pain.
Which medications contain gliptins (DPP-4 inhibitors)?
- Januvia (sitagliptin)
- Onglyza (saxagliptin)
- Tradjenta (linagliptin)
- Nesina (alogliptin)
- Janumet and Janumet XR (metformin and sitagliptin)
- Kombiglyze XR (saxagliptin and metformin)
- Glyxambi (empagliflozin and linagliptin)
- Jentadueto (metformin and linagliptin)
- Kazano (alogliptin and metformin)
- Oseni (alogliptin and pioglitazone)
Why was a FDA safety warning issued for gliptin medications?
The FDA issued the warning due to continued reports of severe joint pain associated with the use of gliptin medications. See More
2013 was a year for many new treatments for type II diabetes. For healthcare workers and patients it’s hard to keep up with the newer medications for the treatment of adult onset diabetes, and treating diabetes is an art and not a “one-size fits all” algorithm. For our folks struggling with type II diabetes the outlook just got brighter because of a class of drugs known as incretin based drugs. Here is the down-low on these medications. See More
For many Americans with health insurance, more than 50 popular brand-name drugs may no longer be covered starting in January 2014. Express Scripts and Caremark, companies that handles pharmacy benefits for more than 200 million Americans, are removing almost 50 brands from their formularies at the end of 2013. More information is below.
What are Express Scripts and Caremark?
Express Scripts and Caremark are companies that administer prescription drug benefits for many health insurance companies and Tricare. See More